Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicingMasaki Ri, Shinsuke Iida|Blood Cancer Journal|2012Cited by 181
Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapyTakuma Narita, Shinsuke Iida|Blood Cancer Journal|2015Cited by 49
Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myelomaTakashi Yoshida, Shinsuke Iida|PLoS ONE|2018Cited by 28